NewAmsterdam Pharma Co N.V. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 1,671.22%13,240.28%-22.04%-1,255.57%-530.25%
EBIT Margin 1,578.20%13,812.50%-3.46%-1,298.56%-386.91%
EBITDA Margin 1.67%16,235.04%-11.21%-1,255.76%-530.15%
Operating Margin 1,578.20%13,812.50%-3.46%-1,298.56%-386.91%
Net Margin 1,671.22%13,240.28%-77.54%-1,255.76%-530.25%
FCF Margin 1,739.24%11,659.26%10.17%-1,002.43%-349.49%
Efficiency
Assets Average 444.72M605.86M
Equity Average 359.23M522.95M
Invested Capital 434.21M300.97M795.01M
Asset Utilization Ratio 0.030.08
Leverage & Solvency
Interest Coverage Ratio -15.78-138.13-12.39
Debt to Equity 0.010.040.05
Debt Ratio 0.010.040.04
Equity Ratio 0.790.830.88
Times Interest Earned -15.78-138.13-12.39
Valuation
Enterprise Value 134.16M173.07M378.96M746.92M1,540.13M
Market Capitalization 134.16M173.07M846.69M1,087.37M2,374.32M
Return Ratios
Return on Sales 16.71%132.40%-0.22%-12.56%-5.30%
Return on Capital Employed -0.46%-0.35%
Return on Invested Capital -0.32%
Return on Assets -0.40%-0.40%
Return on Equity -0.49%-0.46%